By Stan Choe

Stocks were mixed on Wall Street Wednesday, as indexes drifted between small gains and losses through a quiet day of trading.

The S&P 500 edged down by 1.55, or less than 0.1%, to 4,376.86. The Dow Jones Industrial Average slipped 74.08 points, or 0.2%, to 33,852.66, while the Nasdaq composite rose 36.08, or 0.3%, to 13,591.75.

General Mills fell to one of the market's larger drops after the maker of Cheerios and Haagen-Dazs reported weaker revenue for the latest quarter than analysts expected. It sank 5.2% despite reporting stronger profit than expected and giving a forecast for upcoming results that was close to Wall Street’s.

Other food companies also fell, including drops of 4% for Hershey, 3.7% for J.M. Smucker and 3.5% for Conagra Brands.

On the winning side of Wall Street was AeroVironment, which rose 4.9%. The maker of unmanned aircraft, tactical missile systems and other equipment used by the U.S. military and in Ukraine reported stronger profit and revenue for the latest quarter than expected. It also gave a stronger forecast for upcoming results than analysts expected amid what it called a record backlog.

Cruise operators also steamed ahead, continuing a strong year built on expectations for healthy demand for vacations. Carnival jumped 8.8% for the biggest gain in the S&P 500 and has more than doubled so far this year. Norwegian Cruise Line Holdings gained 7.6%, and Royal Caribbean Group gained 1.7%.

A day earlier, other travel-related stocks helped lead the market after Delta Air Lines said it's still seeing pent-up demand from fliers looking to make up for lost time during the pandemic.

Elsewhere in markets, trading was relatively quiet. Stock indexes rose in Europe and were mixed in Asia. Treasury yields fell.

The big question for markets worldwide is whether economies will continue to be able to avoid falling into recession despite the weight of much higher interest rates meant to bring down inflation.

Federal Reserve Chair Jerome Powell reiterated Wednesday that stubborn inflation means interest rates will need to stay high. The Fed has said it expects to raise rates one or two more times this year, while the European Central Bank and others have sounded even more aggressive.

But heads of Western central banks speaking at a conference in Portugal also said their economies have been more resilient than expected and they don’t foresee a contraction.

For now, the U.S. economy has been holding up better than expected thanks in large part to a remarkably resilient job market. Strong reports on consumer confidence, sales of new homes and other areas of the economy on Tuesday helped lead to a 1.1% rally for the S&P 500. Earlier this month, the S&P 500 reached its highest level since April 2022.

“Following some early week jitters, we’ve now seen a return to business-as-usual in global equities. Markets are taking some comfort from U.S. economic indicators which are showing no signs of an imminent ‘hard landing’ with regard to growth,” Tim Waterer, chief market analyst at KCM Trade, said in a report.

Economists are increasingly hopeful a recession may be avoidable, delayed, or that contraction may be limited to specific sectors and not the entire economy.

In the bond market, the yield on the 10-year Treasury fell to 3.70% from 3.77% late Tuesday. It helps set rates for mortgages and other important loans.

The two-year yield, which moves more on expectations for the Fed, sank to 4.70% from 4.76%.

In Europe, stock indexes rose with France's CAC 40 leading the way with a 1% gain.

Japan’s Nikkei 225 jumped 2% as the weakening value of the Japanese yen benefits exporters from the country. Stock indexes elsewhere in Asia moved more modestly and were mixed.

AP Business Writers Yuri Kageyama and Matt Ott contributed.

Updated with latest details.

Share:
More In Business
Stocks Close Mixed as Investors Process Earnings, Look Ahead to Thursday CPI
Stocks closed mixed Monday as a broader tech sell-off continued, leading the Nasdaq to close down 0.58%. Investors are keeping an eye on earnings, and also looking ahead to Thursday's CPI data, which will give an idea of how hot inflation could still be running. Steve Sosnick, Chief Strategist at Interactive Brokers, joins Closing Bell to discuss today's close, the Federal Reserve's plans to raise interest rates and taper asset purchasing, his 2022 market outlook, and more.
Chip Shortage Continues to Impact Automobile Production
The global chip shortage continues to weigh on the automotive industry. For example, Ford says it is suspending or cutting production at eight of its factories in North America through next week due to the shortage. Balu Balakrishnan, President and CEO of Power Integrations, joins Cheddar News' Closing Bell, where he elaborates on why the chip shortage has dragged into 2022.
Dan Ives: Apple is Likely 'Aggressively' Pursuing Peloton Takeover
Peloton has weathered a seemingly never-ending storm the past few months: PR blunders, sinking customer demand, and in recent weeks, reported cost-cutting and potential layoffs. Now, several companies are said to be in the mix as potential buyers: Amazon, Netflix, Disney, and Apple. How likely is it that one of these companies pursues a deal — and how likely is it that it will be Apple who buys Peloton? Dan Ives, Managing Director of Equity Research at Wedbush Securities, joins Closing Bell to discuss his thoughts about Apple pursuing a Peloton takeover,
Astra Scrubs NASA ELaNa 41 Space Launch, Sees Its Stock Fall
Astra aborted the launch for NASA ELaNa 41 Mission out of Cape Canaveral on Monday due to what was described as a minor issue, but the company's stock fell nearly 14 percent following the news. Jim Cantrell, CEO and co-founder of Phantom Space, which builds and launches spacecraft of its own, joined Cheddar to discuss the scrubbed mission. “The last thing you want is for this to go wrong, you're better to err on the side of safety expectations,” Cantrell explained, noting that the mission delay was a normal event.
TC BioPharm Goes Public, Looks to Future of Cancer, COVID-19 Cell Therapies
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
Load More